Simultaneous or staged resection of synchronous colorectal cancer liver metastases: a 13-year institutional follow-up

HPB (Oxford). 2022 Jul;24(7):1091-1099. doi: 10.1016/j.hpb.2021.11.019. Epub 2021 Dec 2.

Abstract

Background: This study compared postoperative outcomes and survival rates of patients who underwent simultaneous or staged resection for synchronous colorectal cancer liver metastases.

Methods: Between 2005 and 2018, 126 patients were registered prospectively at a university hospital in Sweden, 63 patients who underwent simultaneous resection were matched against 63 patients who underwent staged resection.

Results: The length of hospital stay was shorter for the simultaneous resection group, at 11 vs 16 days, p = <0.001. Fewer patients experienced recurrence in the simultaneous resection group 39 vs 50 patients, p = 0.012. There were no significant differences in disease-free survival and overall survival between the groups. Age (hazard ratio [HR] 1.72; 95% CI 1.01-2.94; p = 0.049) and Clavien-Dindo score (HR 2.22; 95% CI 1.06-4.67; p = 0.035) had impact on survival.

Conclusion: Colorectal cancer with synchronous liver metastases can be resected simultaneously, and enables a shorter treatment time without jeopardizing oncological outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colectomy / adverse effects
  • Colorectal Neoplasms* / pathology
  • Follow-Up Studies
  • Hepatectomy / adverse effects
  • Humans
  • Length of Stay
  • Liver Neoplasms*
  • Retrospective Studies
  • Treatment Outcome